Previous 10 | Next 10 |
PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire SOUTH PLAINFIELD, N.J. , Jan. 3, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 42 n...
2023-12-23 05:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-05 17:53:48 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript PTC Therapeutics stock slides after Citi downgrades to Sell PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M ...
PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities PR Newswire SOUTH PLAINFIELD, N.J. , Dec. 5, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today an update on Translarna™ (ataluren) regulatory activities ...
2023-10-29 06:11:08 ET PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Conference Call February 08, 2023, 9:00 AM ET Company Participants Jane Hanlon - Associate Director, Investor Relations Matthew Klein - Chief Executive Officer Eric Pauwels - Chief Business Off...
2023-10-27 09:20:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Align Technology (NASDAQ: ALGN ) stock is on the move Friday after the Invisalign maker announced a $250 million share repurchase program . Align Technology notes that this ...
2023-10-27 09:08:01 ET PTC Therapeutics ( NASDAQ: PTCT ) plunged ~22% premarket on Friday after the Citi downgraded recommendation on its stock to Sell/High Risk. SA Quant system rates the stock as Hold The downgrade follows the company's third quarter earnings a...
2023-10-26 18:02:05 ET Gainers: CVRx ( VRX ) +29% . Eargo ( EAR ) +28% . DexCom ( DXCM ) +15% . Masimo Corporation ( MASI ) +13% . Groupon ( GRPN ) +9% . Losers: Enphase Energy ( ENPH ) -17% . PTC Therapeutics...
2023-10-26 16:28:40 ET More on PTC Therapeutics PTC Therapeutics: Struggling Still But Potential Remains PTC Therapeutics, Inc. (PTCT) Q2 2023 Earnings Call Transcript PTC Therapeutics Q3 2023 Earnings Preview Royalty Pharma to buy up to $1.5B of PTC Therapeu...
PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results PR Newswire – Third quarter 2023 total revenues of $197 million and remain on target for 2023 revenue guidance – – PTC strengthened its financial position fo...
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA PR Newswire WARREN, N.J. , July 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the submission of the sepiapterin NDA to the U.S. FDA. The NDA submission is for the t...
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results PR Newswire WARREN, N.J. , July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to r...
2024-07-12 10:00:03 ET Jeffrey Hung from Morgan Stanley issued a price target of $32.00 for PTCT on 2024-07-12 08:15:00. The adjusted price target was set to $32.00. At the time of the announcement, PTCT was trading at $33.2. The overall price target consensus is at $43....